Search clinical trials for: thoracic stentgraft

Total 12561 results

University Hospital, Limoges
Groupe Français de Pneumologie Cancérologie (GFPC)

Completed

Study of an Early Change of a Chemotherapeutic Doublet Versus Four Cycles of Chemotherapy in Advanced Non Small Cell Lung Cancer

Non Small Cell Lung Carcinoma

France
Eli Lilly and Company

Completed

Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma

Malignant Pleural Mesotherioma

Japan
Eli Lilly and Company

Completed

Neo-Adjuvant Gemcitabine and Cisplatin in Treating Patients With Early Stage of Non Small Cell Lung Cancer

Carcinoma, Non-Small-Cell-Lung Cancer

Turkey
Centro Cardiologico Monzino

Completed

Comparison of Ropivacaine and Levobupivacaine in High Thoracic Epidural Anesthesia

Coronary Artery Bypass | Epidural Anesthesia

Italy
Kentuckiana Cancer Institute

Completed

Iscar for Second Line Treatment of Advanced Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
University Hospital, Limoges

Completed

Follow-up of Patients With Curative-Intent Surgical Resection for NSCLC

Non-Small Cell Lung Cancer

France
Gruppo Italiano MEsotelioma

Unknown

A Phase II Study of the Association of Glivec® Plus Gemzar® in Patients With Unresectable, Refractory, Malignant Mesothelioma

Mesothelioma

Italy
Minneapolis Veterans Affairs Medical Center

Completed

Acetylcysteine in the Prevention of Renal Failure After Bypass Surgery

Kidney Failure

United States
University of Oslo School of Pharmacy

Completed

Metabolic Pattern of Cyclosporine A and Acute Renal Failure

Heart Transplantation | Acute Renal Failure

Norway
MedImmune LLC

Completed

Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer

Esophagitis | Non-Small Cell Lung Carcinoma | Pneumonitis

United States
Abbott

Terminated

Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects With Non-Small Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung

United States
National Taiwan University Hospital

Completed

Iressa as a First-Line Treatment in Chemonaive Patients With Inoperable Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

Taiwan
University Hospital, Geneva

Completed

Prevention of Lung Edema After Thoracic Surgery

Anesthesia | Thoracotomy | Lung Injury, Acute | Extravascular Lung Water | Intensive Care, Surgical

Switzerland
Danish Lung Cancer Group
Ministry of the Interior and Health, Denmark

Unknown

Danish Lung Cancer Screening Trial (DLCST) (DLCST)

Lung Cancer

Denmark
Eli Lilly and Company

Completed

Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose Gemcitabine) in Patients With Lung Cancer With Positive Nodes

Non-Small Cell Lung Cancer

Poland
Eli Lilly and Company

Completed

Trial of Pemetrexed or Pemetrexed With Gemcitabine for Patients With Advanced Lung Cancer Who Are Not Eligible for Platinum-Based Chemotherapy and Have Not Previously Been Treated With Chemotherapy

Non-Small Cell Lung Cancer

Germany, Italy, United Kingdom
Eli Lilly and Company

Completed

Trial Comparing 3 and 4 Week Regimen of Gemcitabine and Cisplatin in Patients With Lung Cancer

Non-Small Cell Lung Cancer

China
University Health Network, Toronto

Unknown

A Clinical Comparison of Three Bronchial Blockers for One-Lung Ventilation in Thoracic Surgery

Thoracic Surgery

Canada
Point Therapeutics

Completed

Study of Talabostat and Docetaxel in Advanced Non-Small Cell Lung Cancer

Lung Cancer

United States
Point Therapeutics

Terminated

Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

Carcinoma, Non-Small-Cell Lung | Lung Cancer | Neoplasms, Lung | Neoplasms, Pulmonary

United States
Point Therapeutics

Terminated

Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

Carcinoma, Non-Small Cell Lung

United States
Pharmacyclics LLC.

Completed

Study of Motexafin Gadolinium and Docetaxel for Advanced Solid Tumors

Breast Neoplasms | Lung Neoplasms | Prostatic Neoplasms | Ovarian Neoplasms

United States
Pharmacyclics LLC.

Completed

Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)

Carcinoma, Non-Small-Cell Lung | Brain Neoplasms | Metastases, Neoplasm

United States, France, Belgium, Germany, Canada, Netherlands, Austria, Australia
Novacea
Aventis Pharmaceuticals

Completed

Study of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States
Pfizer

Completed

A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer

Breast Neoplasms | Carcinoma, Non-Small-Cell Lung | Colorectal Neoplasms | Pancreatic Neoplasms

United States
Eli Lilly and Company

Completed

Enzastaurin as Second and Third-Line Treatment for Non-Small Cell Lung Cancer.

Non-Small-Cell Lung Carcinoma

United States
ActivBiotics

Unknown

RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease

Coronary Artery Disease | Peripheral Vascular Disease | Cerebrovascular Disease

United States, Canada
Grupo Gallego de Cancer de Pulmon

Unknown

Phase II Trial of Tarceva in Patients With Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

Spain
University Health Network, Toronto

Completed

Dose Reduction in Thoracic CT

Lymphoma

Canada
Gunma University

Completed

Fluorine-18-α-Methyltyrosine Positron Emission Tomography for Diagnosis and Staging of Lung Cancer

Carcinoma, Non-Small-Cell Lung
Rambam Health Care Campus

Unknown

Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma

Venous Thromboembolism | Non-Small Cell Lung Carcinoma

Israel
Eli Lilly and Company

Completed

Safety Confirmation Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma

Malignant Pleural Mesothelioma

Japan
Swedish Medical Center
Sanofi-Synthelabo

Terminated

Oxaliplatin/CPT-11 for Extensive Stage Small Cell Lung Cancer

Small Cell Lung Cancer

United States
Beijing Chao Yang Hospital

Unknown

Noninvasive Positive Pressure Ventilation for ALI/ARDS:a Multicentre Randomized Controlled Trial

Acute Respiratory Distress Syndrome | Acute Lung Injury

China
Eli Lilly and Company

Approved for marketing

ALIMTA (Pemetrexed) Alone or in Combination With Cisplatin for Patients With Malignant Mesothelioma.

Mesothelioma

United States, Brazil, Egypt, Saudi Arabia
Hospital Pompeia

Completed

Anesthesia in Flexible Bronchoscopy for Lung Cancer Diagnostic

Lung Cancer

Brazil
Postgraduate Institute of Medical Education and...

Unknown

A Comparative Study of the Safety and Efficacy of Face Talc Slurry and Iodopovidone for Pleurodesis

Primary Spontaneous Pneumothorax | Malignant Pleural Effusions | Recurrent Pleural Effusions | Secondary Spontaneous Pneumothorax

India
National Cancer Center, Korea

Unknown

VATS Lobectomy for Clinical Stage IB or II Lung Cancer

Carcinoma, Non-Small-Cell Lung | Thoracic Surgery, Video-Assisted

Korea, Republic of
Eli Lilly and Company

Completed

Pemetrexed Plus Gemcitabine for Patients With Locally Advanced or Metastatic NSCLC Who Have Not Had Previous Chemotherapy.

Carcinoma, Non-Small-Cell Lung

United States
Eli Lilly and Company

Completed

A Study of Pemetrexed in Small Cell Lung Cancer, Which Has Returned

Carcinoma, Small Cell

United States
Eli Lilly and Company

Completed

A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Alone in the Treatment of Mesothelioma

Mesothelioma

Canada
Eli Lilly and Company

Completed

A Single Arm Phase 2 Study of Pemetrexed as 2nd-Line Treatment of Advanced Non-Small Cell Lung Cancer

Carcinoma, Non-Small Cell Lung

China, Taiwan, Australia, Korea, Republic of, Egypt, Romania, India, Turkey
Eli Lilly and Company

Completed

Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal Mesothelioma

Mesothelioma

United States
Eli Lilly and Company

Completed

Gemcitabine/Platinum Containing Regimens as Preoperative Chemotherapy for Patients With Non Small Cell Lung Cancer

Carcinoma, Non Small Cell Lung

United States
Eli Lilly and Company

Completed

Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Lung Neoplasms

United States
Memorial Sloan Kettering Cancer Center

Completed

Safety and Pharmacokinetics of Jin Fu Kang in Comb w/Docetaxel for Patients w/Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
Eli Lilly and Company

Completed

Study Comparing Short Infusion Vs. Fixed Dose of Cisplatin + Gemcitabine in Non Small Cell Lung Cancer.

Non-Small-Cell Lung Carcinoma

Argentina, Brazil, Chile, Mexico
Eli Lilly and Company
Aventis Pharmaceuticals

Completed

A Randomized Study Evaluating the Feasibility and Activity of Three Different Combination With Gemcitabine as First Line Therapy for Non Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

Italy
Eli Lilly and Company

Completed

Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy in Non Small Cell Lung Cancer

Carcinoma, Non Small Cell Lung

United States
National Cancer Center, Korea

Completed

Early Low Dose Steroid Therapy of Acute Respiratory Distress Syndrome

Postoperative Complications | Acute Respiratory Distress Syndrome | Acute Lung Injury

Korea, Republic of

3

Subscribe